Lisa A. Carey, MD, FASCO, the Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research in the Department of Medicine’s Division of Oncology recently discussed the updated results of the phase 3 PALOMA-3 trial (NCT01942135) in hormone receptor (HR)–positive, HER2-positive breast cancer.